Sofosbuvir-velpatasvir fixed drug combination for the treatment of chronic hepatitis C infection in patients with end-stage renal disease and kidney transplantation | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Sofosbuvir-velpatasvir fixed drug combination for the treatment of chronic hepatitis C infection in patients with end-stage renal disease and kidney transplantation

Gaur N, Malhotra V, Agrawal D, et al. Sofosbuvir-velpatasvir fixed drug combination for the treatment of chronic hepatitis C infection in patients with end-stage renal disease and kidney transplantation. J Clin Exp Hepatol. 2020;10(3):189-193.

Publication Type:

Journal Article

Authors:

Gaur, N; Malhotra, V; Agrawal, D; et, al

Source:

J Clin Exp Hepatol, Volume 10, Issue 3, p.189-193 (2020)

Cited On:

Patients with Renal Impairment

Export Citation:

RIS Format

Top